CYP2E1 and Obesity: For example, one pediatric study of chlorzoxazone, a CYP2E1 substrate, found that overall systemic clearance normalized to weight was significantly higher in children with versus without obesity, while the renal elimination remained unchanged (Gade et al., 2018).